Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 112 for “"Benign prostatic hyperplasia"”.
-
Benign prostatic hyperplasia
Contains fulltext : mmubn000001_222421924.pdf (Publisher’s version ) (Open Access)
-
Treatment of benign prostatic hyperplasia with paclitaxel-loaded microparticles
Benign prostatic hyperplasia (BPH) is the non-cancerous enlargement or hyperplasia of the prostate gland and the most common benign neoplasm of aging men. Its prevalence increases by age, and by age 60, half of all men will have BPH. Although not life-threatening, BPH significantly affects one's …
-
Development of Feedback Microwave Thermotherapy in Symptomatic Benign Prostatic Hyperplasia.
… and safety in the treatment of patients with benign prostatic hyperplasia (BPH). The application of two biophysical equations in the PLFT software is explained. The calculations provide the intraprostatic ?blood flow index? and amount of accumulated coagulation necrosis during treatment. The …
-
Development of Synchrotron Based Imaging Tools for Benign Prostatic Hyperplasia Using an Induced Canine Model
Benign prostatic hyperplasia (BPH) is a disease that develops spontaneously in men and dogs, and the dog is an accepted model to study BPH in men. As the gland can also be the site of a malignant cancer, definitive diagnosis relies on histological evaluation of prostate tissue following an invasive …
-
The role of serotonin in regulation of benign prostatic growth - implications for benign prostatic hyperplasia etiology
… causa quase inexoravelmente hiperplasia benigna da próstata (HBP) nos homens, no entanto a etiologia da HBP é largamente desconhecida. A serotonina (5-HT) é uma amina biogénica produzida pelas células neuroendócrinas da próstata e está presente em altas concentrações na próstata normal, …
-
Evaluating diagnostic and treatment modalities in the management of benign prostatic hyperplasia in the Veterans Administration population
Benign prostatic hyperplasia (BPH), a common prostatic condition among aging males significantly affects quality of life. Though clinical practice guidelines for BPH management have been established, little research has been done to determine adherence to such guidelines. To assess adherence to …
-
β-NGF and its low-affinity receptor (p75ᴸᴺᴳᶠᴿ) in benign prostatic hyperplasia and adenocarcinoma of the prostate
The proteinaceous hormone 6-nerve growth factor (B-NGF) acts on plasmalemmal receptors to cause neural differentiation in uncommitted cells, and growth and maintenance of neural processes. Responding cells show high and low-affinity binding of the hormone. Low-affinity binding is mediated by a …
-
Prostasin Is Expressed In Benign Prostatic Hyperplasia And Regulates Cell Proliferation And Invasion Via Inos, Icam-1, And Cycli
… We examined prostasin expression and function in benign prostatic hyperplasia (BPH). We evaluated prostasin expression in 12 BPH specimens by immunohistochemistry, and evaluated the impact of prostasin silencing by siRNA on the expression of the inducible nitric oxide synthase (iNOS), …
-
Μελέτη της επίδρασης της νυκτουρίας σε άρρενες με συμπτώματα από το κατώτερο ουροποιητικό σύστημα οφειλόμενα στην καλοήθη υπερπλασία του προστάτη αδένα (lower urinary tract symptoms due to benign prostatic hyperplasia – LUTS/BPH)
… with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and no other predisposing factor for nocturia. Methods: The study group included 66 patients (mean age 68.9 years) randomized to receive either tamsulosin 0.4 mg once daily or transurethral prostatectomy (TURP) in order …
-
Κυτταρογενετική και μοριακή κυτταρογενετική μελέτη των νεοπλασιών του προστάτη
… of the prevalent questions concerning all benign diseases of the prostate is whether their presence increases the risk of prostate cancer. Benign prostatic hyperplasia (Benign Prostatic Hyperplasia, BPH) and prostate carcinoma (Prostate Cancer, CaP) are common urologic diseases in the …
-
Successes and failures of evidence based urology
… statistics could be used to the occurrence of benign prostatic hyperplasia was gone and that we had moved to an epoch where symptomatic disease and quality of life were the key issues. I have worked on the creation of the questionnaire-based approach necessary for evaluating the presence of …
-
Prevalencia de pérdida involuntaria de orina en pacientes en postoperatorio de adenomectomía prostática, Hospital Universitario Mayor Méderi, 2021
… The most common urological pathology in men is benign prostatic hyperplasia affecting 50% above the age of 50 years (7,8). One of the treatment options is prostate adenomectomy and one of its main complications is involuntary urine loss, which has a negative impact on the quality of life of …
-
Control of testosterone 5alpha-reductase activity in the human hyperplastic prostate
… to be the active hormone within this organ. Benign prostatic hyperplasia is a common condition in elderly men, and a raised tissue concentration of DHT has been implicated as a possible cause. In this thesis, several compounds which decrease DHT production, by inhibition of the testosterone …
-
Medical Laser-Induced Thermotherapy - Models and Applications
… reference to treatment of liver tumours and benign prostatic hyperplasia. Mathematical models were used to calculate the distribution of light absorption and the subsequent temperature distribution in laser-irradiated tissues. The models were used to investigate the influence on the …
-
Metabolic effects of 5α-reductase inhibition in humans
… in androgen action is desired, including benign prostatic hyperplasia. Although 5αR2 is predominantly expressed in reproductive tissues, both isozymes, but particularly 5αR1, are expressed in metabolic tissues including liver and adipose and both metabolise glucocorticoids as well as …
-
Η συμβολή της ανοσολογικής μελέτης του προστατικού εκκρίματος στην διάγνωση των παθήσεων του προστάτη
… study is an attempt to identify changes in the prostatic fluid indicating high probability of pros-tatic malignancy. Prostatic fluid was collected with massage from patients with prostatic adenocarcinoma, prostatitis and benign prostatic hyperplasia. Immunoglobulins IgA and I g G, complements C^ …
-
Non-adrenergic non-cholinergic innervation of lower urinary tract after partial bladder outlet obstruction in guinea pig
Benign prostatic hyperplasia (BPH) is the commonest pathological conditionaffecting elderly males, but the underlying pathophysiological changes of BPH haveremained uncertain. Clinically, the use of either anti-cholinergic drugs or alpha-1receptor antagonists has not been very satisfactory in the …
-
Η ΣΥΜΒΟΛΗ ΤΩΝ ΑΚΤΙΝΩΝ LASER ΣΤΗΝ ΑΝΤΙΜΕΤΩΠΙΣΗ ΤΗΣ ΚΑΛΟΗΘΟΥΣ ΥΠΕΡΠΛΑΣΙΑΣ ΤΟΥ ΠΡΟΣΤΑΤΗ
FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA,TRANSURETHRAL RESECTION OF THE PROSTATE(TURP)REMAINS THE BEST TREATMENT MODALITY.IN THE LAST COUPLE OF YEARS MANY OTHER TREATMENT OPTIONS HAVE APPEARED SUCH AS THERMOTHERAPY,CRYOTHERAPY AND MEDICAL TREATMENT BUT NONE OF THESE ALTERNATIVE THERAPIES …
-
Ο πιθανός ρόλος των γλυκοζαμινογλυκανών στη διαφοροδιαγνωστική προσέγγιση του προστατικού αδενοκαρκινώματος
… sulphate (CS) is accumulated around acini in benign prostatic hyperplasia (BPH) and in prostatic adenocarcinoma (PCa). In addition CS is a marker of poor prognosis in PCa. MCs are responsible directly or indirectly -by interacting with fibroblasts- for CS production, whilst CS influences MCs …
Page 1 of 6